The rise in chronic diseases, advancements in technology, and a strong research and development pipeline have ignited a heightened demand for pharmaceutical products and services. Moreover, the pharmaceutical sector's resilience to economic fluctuations offers a stable environment for companies operating within this industry.
Given the industry’s stability, this article sheds light on the fundamentals of three promising pharma stocks, Amneal Pharmaceuticals, Inc. (AMRX), AbbVie Inc. (ABBV), and GSK plc (GSK), which might be ideal buys now.
